The Christie Foundation Trust Annual Report and Accounts 2021-22

Performance Key Indicators

Yearly position

National targets and minimum standards

Threshold 2021/22 Q1 Q2 Q3 Q4

Target

39

Number of Attributable C-Diff cases Number of MRSA Bacteraemia

31

12

11

9 0

7 0

0

Infection control

0

0

0

100%

MRSA Screening

100% 100% 100% 100% 100%

% of cancer patients waiting a maximum of 31 days for diagnosis to first definitive treatment % of cancer patients waiting a maximum of 31 days for subsequent treatment (anti- cancer drugs) % of cancer patients waiting a maximum of 31 days for subsequent treatment (surgery) % of cancer patients waiting a maximum of 31 days for subsequent treatment (radiotherapy) % of cancer patients waiting a maximum of 62 days from GP referral to first definitive treatment including rare and testicular cancers (based on national allocated position). % of cancer patients waiting a maximum of 62 days from consultant upgrade date to first definitive treatment including rare and testicular cancers (based on national allocated position). % of cancer patients waiting a maximum of 62 days from screening referral to first definitive treatment (based on national allocated position)

96% 98.3% 98.9% 99.5% 97.2% 98.5%

98% 100.0% 100.0% 100.0% 99.9% 100.0%

94% 99.4% 99.7% 100.0% 100.0% 99.7%

94% 99.9% 99.9% 99.8% 99.3% 99.8%

**Cancer Targets

85% 83.4% 82.8% 81.4% 73.0% 80.4%

85% 87.9% 84.7% 84.9% 76.8% 83.6%

90% 100.0% 90.9% 75.0% 85.7% 86.7%

92% 99.7% 99.1% 98.4% 98.3% 98.3% 99% 98.1% 98.8% 98.9% 97.9% 98.4%

18 Weeks

18 week incomplete pathways

6 Weeks diagnostic waits

Maximum 6 week wait for diagnostic procedures

**These indicators are below threshold throughout 2021/22 due to the COVID-19 pandemic, some services were suspended, therefore creating a backlog across Greater Manchester.

90